Background
Methods
Statistical analysis
Results
Variables | Group 1 (25) | Group 2 (22) | Group 3 (26) | Group 4 (20) | P value |
---|---|---|---|---|---|
Age (years) | 0.35 | ||||
X ± SD | 51.72 ± 5.8 | 49.13 ± 9.11 | 49.84 ± 3.7 | 51.75 ± 4.15 | |
Gender | |||||
Male | 13 (52%) | 10 (45.5%) | 16 (61.5%) | 11 (55%) | 0.73 |
Female | 12 (48%) | 12 (54.5%) | 10 (38.5%) | 9 (45%) | |
Duration (years) | 0.001* | ||||
Median (range) | 3 (1–10) | 3 (1–11) | 4 (1–24) | 10 (2–24) | |
Smoking | 1 (4%) | 1 (4.5%) | 5 (19.2%) | 3 (15%) | 0.22 |
BMI category | |||||
18–25 | 1 (4%) | ||||
>25–30 | 5 (20%) | 7 (31.8%) | 6 (23.1%) | 5 (25%) | 0.74 |
>30 | 19 (76%) | 15 (68.2%) | 20 (76.9%) | 15 (75%) | |
SBP (mmHg) | 0.41 | ||||
X ± SD | 138.8 ± 26.42 | 149.09 ± 26.48 | 139.62 ± 26.34 | 146.5 ± 17.45 | |
Range | 130 (110–200) | 152.5 (110–200) | 127.5 (110–180) | 150 (120–170) | |
DBP (mmHg) | 0.13 | ||||
X ± SD | 86.8 ± 10.09 | 91.13 ± 7.54 | 87.3 ± 8.74 | 91.75 ± 8.15 | |
Range | 85 (70–120) | 95 (80–100) | 85 (75–100) | 95 (80–100) | |
HTN | 5 (20%) | 13 (59.1%) | 11 (42.3%) | 14 (70%) | 0.004 |
IHD | 2 (8%) | 4 (18.2%) | 2 (7.7%) | 3 (15%) | 0.61 |
HCT | 2 (8%) | 4 (18.2%) | 6 (23.1%) | 5 (25%) | 0.43 |
Neuropathy | 0 | 1 (4.5%) | 6 (23.1%) | 6 (30%) | 0.008 |
CRP (mg/l) X ± SD | 9.6 ± 3 | 13.41 ± 4.59 | 14.35 ± 1.54 | 19.8 ± 2.59 | 0.0001◊#
|
Variables | Group 1 | Group2 | Group 3 | Group 4 | P value |
---|---|---|---|---|---|
BMI kg/m2
| 34.4 ± 6.41 | 33.35 ± 5.59 | 32.24 ± 3.58 | 31.19 ± 3.41 | 0.16 |
FBG mg/dl | 132.28 ± 21.57 | 131.59 ± 26.65 | 171.08 ± 25.71 | 179.6 ± 66.04 | 0.0001◊
|
126 (73) | 111 (100) | 151 (59) | 144 (172) | ||
PPBG mg/dl | 166.36 ± 45.95 | 192.91 ± 37.23 | 200.13 ± 8.05 | 278.95 ± 15.1 | 0.0001◊
|
155 (83–260) | 194 (140–285) | 201 (178–244) | 290 (250–360) | ||
HbA1C% | 6.83 ± 1.24 | 7.98 ± 1.17 | 8.49 ± 1.26 | 9.67 ± 1.64 | 0.0001◊#
|
TC mg/dl | 174.84 ± 25.46 | 183.5 ± 35.39 | 172.6 ± 34.48 | 176.85 ± 44.97 | 0.74 |
TG mg/dl | 148.64 ± 60.06 | 159.86 ± 53.83 | 168.77 ± 75.1 | 219 ± 93.28 | |
136 (90–290) | 143.5 (99–296) | 140 (112–400) | 208.5 (111–340) | 0.01* | |
LDLc mg/dl | 103.08 ± 23.37 | 102.314 ± 28 | 110.65 ± 29.32 | 106.8 ± 22.27 | 0.65 |
HDLc | 43.8 ± 10.87 | 42.68 ± 8.81 | 40.654 ± 5.72 | 35.05 ± 7.29 | 0.005* |
41 (28–70) | 38 (33–67) | 40 (30–50) | 32.5 (29–53) | ||
LDLc/HDLc | 2.49 ± 0.83 | 2.51 ± 0.91 | 2.89 ± 1.31 | 3.21 ± 1.02 |
0.09
|
3.11 (1.21–4.04) | 2.53 (1.34–4.97) | 2.83 (1.48–6) | 3.28 (1.64–4.28) | ||
s.creatinine mg/dl | 0.95 ± 0.04 | 0.95 ± 0.07 | 0.97 ± 0.07 | 0.94 ± 0.04 |
0.58
|
0.9 (0.84–1.05) | 0.97 (0.84–1.09) | 0.98 (0.85–1.08) | 0.94 (0.85–1) | ||
Urea mg/dl | 28.76 ± 3.45 | 27.81 ± 2.38 | 27.92 ± 1.67 | 28.35 ± 2.1 | 0.55 |
MDA μM | 9.62 ± 2.57 | 8.05 ± 2.63 | 10.38 ± 2.65 | 9.6 ± 3.68 |
0.026
|
9 (5–12) | 8.5 (4–13) | 9 (7–12) | 8 (7–14) | ||
OxLDLc pg/ml | 1272.5 ± 395.35 | 1558.3 ± 552.7 | 1590.3 ± 586.57 | 1518.4 ± 292.61 | |
1090 (600–2600) | 1122 (625–2740) | 1315 (670–2550) | 1156 (880–2505) |
0.031
| |
OxLDLc/LDLc | 11.47 ± 3.02 | 15.28 ± 7.44 | 14.76 ± 5.95 | 15.09 ± 4.92 |
0.069
|
10.9 (6.7–18.4) | 14.4 (5.4–37.5) | 13.1 (6.5–25) | 15.5 (9.1–24.2) | ||
OxLDLc/HDLc | 31.38 ± 11.61 | 37.49 ± 13.69 | 39.81 ± 15.42 | 44.13 ± 11.99 |
0.002
|
26.1 (16.8–62.3) | 32.5 (23–73.2) | 38.7 (15.9–67.2) | 38.8 (32.5–66.3) |
Variables | Group 1 | Group 2 | Group 3 | Group 4 | P value |
---|---|---|---|---|---|
BMI kg/m2
| 34.64 ± 7.07 | 32.97 ± 5.53 | 31.41 ± 3.73 | 30.73 ± 3.29 | 0.054 |
FBG mg/dl | 127.8 ± 17.48 | 126.05 ± 23.31 | 150.58 ± 10.03 | 164.85 ± 47.51 | 0.0001•
|
124 (78) | 111.5 (96) | 150 (60) | 140 (151) | ||
PPBG mg/dl | 157.2 ± 35.71 | 179.32 ± 30.01 | 182.27 ± 8.72 | 249.5 ± 15.71 | 0.0001#•
|
153 (135) | 189 (145) | 200 (32) | 282 (52) | ||
HbA1C% | 6.77 ± 0.84 | 7.73 ± 1.17 | 7.76 ± 0.93 | 8.85 ± 1.72 | 0.0001#”
|
TC mg/dl | 172.6 ± 25.42 | 182.41 ± 36.29 | 171.08 ± 35.02 | 174.5 ± 44.31 | 0.69 |
TG mg/dl | 147.54 ± 59.01 | 157.66 ± 51.63 | 166.67 ± 73.01 | 217 ± 91.26 | |
136 (90–290) | 143.5 (99–296) | 140 (112–400) | 208.5 (111–340) | 0.02* | |
LDLc mg/dl | 99.28 ± 18.54 | 93.68 ± 26.66 | 112.42 ± 28.83 | 94.15 ± 19.86 | 0.027◊
|
HDLc | 43.88 ± 9.47 | 41.09 ± 7.77 | 42.46 ± 4.39 | 32.85 ± 4.74 | 0.0001#
|
40 (35) | 40 (26) | 43.5 (17) | 32 (16) | ||
LDcL/HDLc | 2.37 ± 0.67 | 2.38 ± 0.88 | 2.75 ± 1.11 | 2.92 ± 0.71 |
0.048
|
22 (2.4) | 2.13 (3.15) | 2.47 (4.49) | 2.73 (2.33) | ||
s.creatinine mg/dl | 0.95 ± 0.04 | 0.95 ± 0.06 | 0.96 ± 0.06 | 0.94 ± 0.04 |
0.56
|
0.9 (0.84–1.05) | 0.97 (0.84–1.09) | 0.98 (0.85–1.08) | 0.94 (0.85–1) | ||
Urea mg/dl | 28.70 ± 3.42 | 27.8 ± 2.36 | 27.9 ± 1.65 | 28.35 ± 2.1 | 0.53 |
MDA μM | 8.4 ± 2.55 | 8.04 ± 2.72 | 7.34 ± 1.87 | 8.7 ± 2.58 |
0.29
|
7.1 (8) | 8 (10.8) | 7 (5.5) | 8.5 (7) | ||
OxLDLc pg/ml | 1135.4 ± 427.5 | 1063.8 ± 513.64 | 1277.3 ± 590.4 | 1263.4 ± 1064.5 |
0.22
|
980 (1976) | 1011.5 (2030) | 1065 (1916) | 874 (3206) | ||
OxLDLc/LDLc | 10.26 ± 3.83 | 10.16 ± 5.47 | 11.86 ± 5.55 | 13.48 ± 12.95 |
0.54
|
9.77 (16.67) | 9.17 (27.18) | 11.83 (17.11) | 8.84 (40.5) | ||
OxLDLc/HDLc | 29.17 ± 16.86 | 26.32 ± 14.49 | 32.12 ± 15.91 | 37.86 ± 36.35 |
0.39
|
23.08 (72.83) | 21.52 (55.64) | 28.05 (49.47) | 21.85 (106.44) |
Variables | Group 1 | Group 2 | Group 3 | Group 4 |
---|---|---|---|---|
HbA1C1 | 6.83 ± 1.24 | 7.98 ± 1.17 | 8.49 ± 1.26 | 9.67 ± 1.64 |
HbA1C3 | 6.77 ± 0.8 | 7.73 ± 1.17 | 7.76 ± 0.93 | 8.85 ± 1.72 |
Reduction in HbA1C | −0.06 ± 1.04 | −0.25 ± 0.72 | −0.73 ± 1.27 | −0.82 ± 0.78 |
P value within group | P = 0.97
| P = 0.39
| P = 0.023
| P = 0.11
|
OxLDLc1 | 1272.5 ± 395.35 | 1558.3 ± 552.74 | 1590.3 ± 586.57 | 1518.4 ± 292.61 |
OxLDLc3 | 1135.4 ± 427.51 | 1063.8 ± 513.64 | 1277.3 ± 590.41 | 1263.4 ± 1064.56 |
Reduction in oxLDLc | −137.1 ± 517.52 | −494.5 ± 625.1 | −312.9 ± 514.55 | −255 ± 931.2 |
−131(−1744–870) | −513.5(−2066–1255) | −391(−1100–833) | −639(−1379–1585) | |
P value within group | P = 0.044
| P = 0.002
| P = 0.017
| P = 0.002
|
OxLDL/LDLc1 | 11.47 ± 3.02 | 15.28 ± 7.43 | 14.76 ± 5.95 | 15.09 ± 4.92 |
OxLDLc/LDLc3 | 10.26 ± 3.83 | 10.16±5.47 | 11.86 ± 5.55 | 13.48 ± 12.95 |
Reduction in oxLDLc/LDLc | −1.2 ± 4.08 | −5.12 ± 5.03 | −2.89 ± 4.53 | −1.62 ± 9.92 |
−1.38(−10.38–7.7) | −5.5(−13.11–7.22) | −2.34(−11.96–5.37) | −4.96(−11.83–19.33) | |
P value within group | P = 0.15
| P = 0.009
| P = 0.07
| P = 0.018
|
OxLDL/HDLc1 | 31.38 ± 11.61 | 37.49 ± 13.69 | 39.81 ± 15.42 | 44.13 ± 11.99 |
OxLDL/HDLc3 | 29.17 ± 16.86 | 26.32 ± 14.49 | 32.12 ± 15.91 | 37.86 ± 36.36 |
Reduction in oxLDLc/HDLc | −2.21 ± 12.76 | −11.18 ± 15.93 | −7.68 ± 12.84 | −6.28 ± 29.43 |
−2.98(−32.3–30) | −12.88(−54.39–35.88) | −7.82(−25–22.51) | −15.98(−47.55–52.83) | |
P value within group | P = 0.11
| P = 0.001
| P = 0.05
| P = 0.002
|
MDA1 | 9.62 ± 2.56 | 8.05 ± 2.63 | 10.38 ± 2.65 | 9.6 ± 3.68 |
MDA3 | 8.41 ± 2.55 | 8.04 ± 2.72 | 7.34 ± 1.87 | 8.7 ± 2.58 |
Reduction in MDA | −1.2 ± 3.34 | −0.01 ± 3.37 | −3.03 ± 2.95 | −0.9 ± 3.55 |
−1.2(−7–7) | −1.5 (−8–6) | −2(−9–0.8) | −0.5(−8–4) | |
P value within group | P = 0.1
| P = 0.93
| P = 0.0001
| P = 0.31
|
OxLDLc1 | MDA1 | OxLDLc3 | MDA3 | CRP | ||||||
---|---|---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | r | P | |
Age | 0.089 | 0.39 | −0.13 | 0.22 | 0.15 | 0.15 | 0.17 |
0.09
| 0.03 | 0.77 |
Gender | 0.1 | 0.034 | 0.04 | 0.69 | −0.28 | 0.007 | −0.009 | 0.94 | −0.13 | 0.22 |
Smoking | −0.12 | 0.24 | 0.027 | 0.79 | −0.16 | 0.12 | 0.08 | 0.45 | −0.11 | 0.28 |
D/duration | 0.09 | 0.42 | −0.06 | 0.53 | 0.03 | 0.8 | 0.05 | 0.65 | 0.29 |
0.004
|
BMI | −0.25 | 0.014 | 0.15 | 0.15 | 0.21 | 0.049 | −0.03 | 0.82 | −0.23 |
0.025
|
Neuropath | 0.25 |
0.015
| −0.08 | 0.4 | 0.14 | 0.19 | 0.02 | 0.88 | 0.29 |
0.004
|
FBG | −0.007 | 0.95 | 0.3 |
0.002
| 0.01 | 0.92 | −0.07 | 0.49 | 0.23 |
0.025
|
PPBG | 0.25 |
0.015
| 0.16 | 0.13 | −0.08 | 0.47 | 0.11 |
0.28
| 0.65 |
0.000
|
HbA1C | 0.09 | 0.39 | 0.16 | 0.12 | −0.16 |
0.13
| 0.16 | 0.12 | 0.39 |
0.000
|
TC | −0.014 | 0.39 | −0.09 | 0.36 | −0.06 | 0.58 | 0.07 | 0.49 | −0.008 | 0.94 |
TG | 0.1 | 0.33 | 0.03 | 0.75 | −0.04 | 0.71 | 0.19 | 0.065 | 0.32 |
0.002
|
LDLc | 0.03 | 0.79 | 0.15 | 0.15 | 0.12 | 0.24 | 0.001 | 0.99 | 0.07 | 0.52 |
HDLc | 0.03 | 0.75 | 0.01 | 0.9 | 0.03 | 0.76 | 0.019 | 0.86 | −0.25 |
0.014
|
LDLc/HDLc | 0.13 | 0.9 | 0.06 | 0.56 | 0.08 | 0.44 | −0.06 | 0.55 | 0.15 | 0.12 |
S.creatinin | 0.17 | 0.11 | −0.006 | 0.95 | 0.34 |
0.001
| 0.07 | 0.51 | −0.03 | 0.79 |
Urea | −0.09 | 0.37 | −0.2 | 0.053 | 0.23 |
0.03
| 0.23 | 0.025 | 0.06 | 0.57 |
CRP | 0.26 |
0.013
| 0.04 | 0.7 | 0.02 | 0.85 | 0.19 | 0.06 |
Variables | OxLDLc1 | OxLDLc3 | ||||
---|---|---|---|---|---|---|
B | CI | P | B | CI | P | |
Smoking | −0.042 | (−452–320.9) | 0.74 | 0.024 | (−609–505) | 0.85 |
Gender | 0.31 | (103–490) |
0.003
| −0.13 | (−458–103) | 0.21 |
SBP | 0.76 | (7.2–22.9) |
0.0001
| 0.78 | (9–32) |
0.0001
|
DBP | −0.79 | (−65–21.8) |
0.0001
| −0.54 | (−72–8) |
0.013
|
Neuropathy | −0.76 | (−493–279) | 0.58 | 0.08 | (−395–704) | 0.58 |
FBG | −0.15 | (−3.9–0.51) | 0.13 | −0.059 | (−5.7–3.1) | 0.57 |
PPG | 0.26 | (0.53–4.44) |
0.013
| 0.12 | (−1.5–5.3) | 0.28 |
S. creatinine | 0.4 | (1487–5080) |
0.0001
| 0.25 | (204–534) |
0.035
|